Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Apoptosis-inducing hydrazones as novel antitumor agents

Dec. 9, 2002

Vertex researchers describe novel series of ERK inhibitors

Dec. 9, 2002

CeMines and CePeP enter pilot program for peptide-based cancer drugs

Dec. 9, 2002

No cytotoxic effect reported for seocalcitol monotherapy in pancreatic cancer

Dec. 9, 2002

High response rate found for temozolomide plus celecoxib in recurrent malignant glioma

Dec. 9, 2002

Allos to begin rolling NDA submission for RSR-13

Dec. 5, 2002

Swissmedic approves Glivec for first-line treatment of CML

Dec. 5, 2002

Preclinical efficacy of Cerebragel in brain cancer

Dec. 5, 2002

Sankyo scientists prepare benzopyran compounds with multiple mechanisms of action

Dec. 5, 2002

T-138067 inactive in astrocytoma and glioblastoma multiforme

Dec. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...